India’s FMCG market is becoming more difficult for smaller brands, with only 56% of low-penetration brands growing their consumer reach in ...

The government has initiated 950 enforcement actions against pharmaceutical companies since December 2022. These actions aim to improve the...

During the first quarter of fiscal 2027, India's pharmaceutical exports soared to $8.10 billion, showcasing remarkable strength in drug for...

The Indian supplements market is anticipated to soar to nearly fifty-seven billion dollars by twenty thirty, driven by heightened consumer ...

Independence Day 2026: Butto Kristo Paul & Co. started as a modest establishment focused on importing foreign medicines. Over time, it blos...

India and the Southern African Customs Union signed terms to start trade negotiations. This move revives talks after previous rounds stalle...

Marksans Pharma shares surged after Q1FY27 profit jumped 174% YoY to Rs 159 crore. Revenue rose 35.6% to Rs 841 crore, while EBITDA hit a r...

India is strengthening supply chains by prioritizing energy and semiconductor sectors. The nation aims to reduce import dependence through ...

India’s medical device industry and healthcare groups have opposed the draft Drugs, Medical Devices and Cosmetics Bill, 2026, arguing that ...

India and the SACU group will sign terms of reference for trade talks. Negotiations for a preferential trade agreement are expected to begi...

Akums Drugs shares rose sharply on Monday to hit a 52-week high after the company reported strong Q1 FY27 results. Revenue rose 13.9% year-...

In a significant development, CNH India has witnessed a 42 percent rise in domestic tractor sales, securing its highest market share to dat...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

Will be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.

Gland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer...

Emcure Pharmaceuticals reported a 23% revenue increase in the first quarter. Ebitda grew 25.8% with improved margins, reflecting productivi...

India's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...